| budesonide/formoterol / Generic mfg. |
NCT00569712: Studying Genes in Blood and Lung Fluid Samples From Patients With Chronic Obstructive Pulmonary Disease With or Without a Previous Diagnosis of Lung Cancer or With Asthma Treated With Budesonide and Formoterol |
|
|
| Completed | 1 | 30 | Canada | budesonide/formoterol fumarate dihydrate inhalation aerosol, DNA methylation analysis, comparative genomic hybridization, microarray analysis, bronchoalveolar lavage, immunoenzyme technique, laboratory biomarker analysis, bronchoscopy | British Columbia Cancer Agency, AstraZeneca | Lung Cancer, Precancerous Condition | 12/08 | 12/08 | | |
| Completed | 1 | 20 | Europe | Budesonide/formoterol 320/9 μg and 400/12 μg inhalers, Symbicort 320/9 μg inhaler | Orion Corporation, Orion Pharma | Asthma | 10/10 | 11/10 | | |
NCT01386996: Comparison of Budesonide and Formoterol Absorption From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler |
|
|
| Completed | 1 | 74 | Europe | Budesonide/formoterol Easyhaler 320/9 microg, Symbicort Turbuhaler forte | Orion Corporation, Orion Pharma | Asthma | 11/11 | 11/11 | | |
NCT01593826: Comparison of Absorption of Budesonide and Formoterol From Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler |
|
|
| Completed | 1 | 72 | Europe | Charcoal and Budesonide/formoterol Easyhaler 320/9 microg, Charcoal and Symbicort Turbuhaler, Budesonide/formoterol Easyhaler 320/9 microg, Symbicort Turbuhaler forte | Orion Corporation, Orion Pharma | Asthma | 10/12 | 10/12 | | |
ADECO, NCT01627158: Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte |
|
|
| Completed | 1 | 72 | Europe | Budesonide/formoterol Easyhaler, Symbicort Turbuhaler, Charcoal and Budesonide/formoterol Easyhaler, Charcoal and Symbicort Turbuhaler | Orion Corporation, Orion Pharma | Asthma | 10/12 | 10/12 | | |
REFLI, NCT01668121: Pharmacokinetic Study on Budesonide/Formoterol Device-metered Dry Powder Inhalers |
|
|
| Completed | 1 | 48 | Europe | Symbicort Turbohaler, Budesonide/formoterol Easyhaler | Orion Corporation, Orion Pharma | Asthma | 11/12 | 11/12 | | |
NCT02237508: A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers |
|
|
| Completed | 1 | 90 | Europe | Z7200 without oral activated charcoal, budesonide/formoterol, Symbicort Turbohaler without oral activated charcoal, Z7200 with oral activated charcoal, budesonide/formoterol with coadministration of charcoal, Symbicort Turbohaler with oral activated charcoal | Zambon SpA | Asthma | 02/15 | 02/15 | | |
NCT03073057: Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler |
|
|
| Completed | 1 | 20 | Europe | Budesonide/formoterol, Budesonide/formoterol 160/4.5microg, Charcoal, Symbicort Turbuhaler, Symbicort Turbuhaler 160/4.5 microg | Orion Corporation, Orion Pharma | Asthma | 03/16 | 03/16 | | |
NCT02850484: A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers With Charcoal Block |
|
|
| Completed | 1 | 99 | RoW | Budesonide, Formoterol | Intech Biopharm Ltd. | Asthma, Chronic Obstructive Pulmonary Disease (COPD) | 05/16 | 05/16 | | |
NCT02631941: Clinical Study to Evaluate Z7200 Pharmacokinetics Profile |
|
|
| Completed | 1 | 91 | Europe | Z7200 without oral activated charcoal, budesonide/formoterol, Symbicort Turbohaler without oral activated charcoal, Z7200 with oral activated charcoal, budesonide/formoterol with coadministration of charcoal, Symbicort Turbohaler with oral activated charcoal | Zambon SpA | Asthma | 07/16 | 07/16 | | |
NCT04494321: A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block |
|
|
| Completed | 1 | 99 | RoW | Budesonide, Formoterol | Intech Biopharm Ltd. | Asthma, COPD | 11/17 | 11/17 | | |
